Oral N-Acetyl cysteine lowered IL 6 level among stage V chronic kidney disease patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

Oral N-Acetyl cysteine lowered IL 6 level among stage V chronic kidney disease patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

Background. IL 6  level is increased in stage V CKD patients on CAPD. N-Acetyl Cysteine is a compound containing thiol with antioxidant and anti-inflammatory effects. Objective. To examine the effect of oral NAC on IL 6 level in stage V CKD patients on CAPD. Method. An experimental research with R...

Full description

Bibliographic Details
Main Author: Evi Nurhayatun
Format: Article
Language:English
Published: Faculty of Medicine 2017-12-01
Series:JKKI (Jurnal Kedokteran dan Kesehatan Indonesia)
Subjects:
N-Acetyl Cysteine, CAPD, IL 6
Online Access:https://journal.uii.ac.id/JKKI/article/view/8957

Similar Items

Similar Items